Literature DB >> 17345039

Hyperhomocysteinemia is a risk factor of middle cerebral artery stenosis.

Hai Wei Huang1, Ming Hui Guo, Rui Jin Lin, Ya Li Chen, Qin Luo, Ying Zhang, Ka Sing Wong.   

Abstract

PURPOSE: Hyperhomocysteinemia (HHcy) is considered to be an independent risk factor for atherosclerosis. We aimed to determine the relation between Hcy and cerebral artery stenosis in a large Chinese population.
METHODS: We present data concerning 2,500 residents. Plasma was saved from 1,020 residents who were asymptomatic. Hcy concentration was measured by fluorescence ration biochemical assay kit, and middle cerebral artery (MCA) was assessed by Transcranial Doppler in these subjects.
RESULTS: Fifty-six residents with MCA stenosis were included in this study. The remained 964 residents without stenosis were control. Analysis of the data revealed that the plasma concentration of Hcy (18.33+/-5.34 micromol/L), age (63.9+/-12.9) and systolic pressure (142.6+/-22.6 mmHg) in the stenotic group were increased (p<0.0001) compared with the control group (Hcy12.95+/-4.57 micromol/L, age 55.8+/-10.9, systolic pressure 126.3+/-20.3 mmHg). Based on logistic regression, 5 factors emerged as independent predictors of MCA stenosis: Hcy (OR=1.16, 95%confidence interval 1.14-1.26), male (OR=2.63, 95%CI 1.49-4.66), age (OR=1.04, 95%CI 1.01-1.07), hypertension (OR=9.16, 95%CI 4.57-18.35), diabetes mellitus (OR=5.90, 95%CI 3.09-11.29).
CONCLUSION: Hyperhomocysteinemia might be one of the risk factors for cerebral artery stenosis. It may play a role in atherosclerosis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345039     DOI: 10.1007/s00415-006-0377-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Homocysteine in cerebral macroangiography and microangiopathy.

Authors:  K Fassbender; O Mielke; T Bertsch; B Nafe; S Fröschen; M Hennerici
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

2.  Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.

Authors:  M R Malinow; A G Bostom; R M Krauss
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

3.  Hyperhomocysteinemia: an independent risk factor for vascular disease.

Authors:  R Clarke; L Daly; K Robinson; E Naughten; S Cahalane; B Fowler; I Graham
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

4.  A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia.

Authors:  J Møller; G M Nielsen; K C Tvedegaard; N T Andersen; P E Jørgensen
Journal:  Scand J Clin Lab Invest       Date:  2000-10       Impact factor: 1.713

5.  Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?

Authors:  W G Christen; U A Ajani; R J Glynn; C H Hennekens
Journal:  Arch Intern Med       Date:  2000-02-28

6.  Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.

Authors:  Eva Hogervorst; Helen Mendes Ribeiro; Andrew Molyneux; Marc Budge; A David Smith
Journal:  Arch Neurol       Date:  2002-05

7.  Intracranial stenosis in Chinese patients with acute stroke.

Authors:  K S Wong; Y N Huang; S Gao; W W Lam; Y L Chan; R Kay
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

8.  Homocysteine in neuropsychiatric disorders of the elderly.

Authors:  Sharon Reutens; Perminder Sachdev
Journal:  Int J Geriatr Psychiatry       Date:  2002-09       Impact factor: 3.485

Review 9.  Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment. off.

Authors:  J H Stein; P E McBride
Journal:  Arch Intern Med       Date:  1998-06-22

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  2 in total

1.  Intracranial artery stenosis: Current status of evaluation and treatment in China.

Authors:  Bin Cai; Bin Peng
Journal:  Chronic Dis Transl Med       Date:  2017-11-14

2.  Lack of association between serum homocysteine level and middle cerebral artery stenosis.

Authors:  Haitao Zhou; Chao Huang; Ruihua Liu; Chao Liu; Congmin Ma; Xiangyang Ren
Journal:  Brain Behav       Date:  2019-06-21       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.